Product Images Kirsty

View Photos of Packaging, Labels & Appearance

  1. Figure 1. Structural formula of insulin aspart-xjhz - image 01
  2. Figure 2. Serial mean serum glucose collected up to 6 hours following a single 0.15 units/kg pre-meal dose of insulin aspart (solid curve) or regular human insulin (hatched curve) injected immediately before a meal in 22 patients with type 1 diabetes - image 02
  3. Figure 4 - image 03
  4. Instructions for Use Prefilled Pen - image 04
  5. Image-5 Instructions for Use Vial - image 05
  6. Image-6: Instructions for Use Dose Vial - image 06
  7. Image-7: Instructions for Use Vial Figures A and B - image 07
  8. Image-8: Instructions for Use Vial Figure C - image 08
  9. Image-9:Instructions for Use Vial Figure D - image 09
  10. image-10:Instructions for Use Vial Figure E - image 10
  11. Image-11:Instructions for Use Vial Figures F and G - image 11
  12. Image-12:Instructions for Use Vial Figure H - image 12
  13. Image-13:Instructions for Use Vial Figure I - image 13
  14. Image-14:Instructions for Use Vial Figure J - image 14
  15. image-15:Instructions for Use Vial Figure K - image 15
  16. Image-16:Instructions for Use Vial Figure L - image 16
  17. Figure 3. Mean blood glucose profiles following intravenous infusion of insulin aspart (hatched curve) and regular human insulin (solid curve) in 16 patients with type 1 diabetes. R represents the time of autonomic reaction. - image 17
  18. Instructions for Use Prefilled Pen Ultra-Fine - image 18
  19. Instructions for Use Prefilled Pen Figure A - image 19
  20. Instructions for Use Prefilled Pen Figure B - image 20
  21. Instructions for Use Prefilled Pen Figure C - image 21
  22. Instructions for Use Prefilled Pen Figure D - image 22
  23. Instructions for Use Prefilled Pen Figure E - image 23
  24. Instructions for Use Prefilled Pen Figure F - image 24
  25. Instructions for Use Prefilled Pen Figure G - image 25
  26. Instructions for Use Prefilled Pen Figure H - image 26
  27. Instructions for Use Prefilled Pen Figure I - image 27
  28. Instructions for Use Prefilled Pen Figure J - image 28
  29. Instructions for Use Prefilled Pen Figure K - image 29
  30. image-33 - image 33
  31. image-34 - image 34
  32. image-35 - image 35
  33. image-36 - image 36

Product Label Images

The following 33 images provide visual information about the product associated with Kirsty NDC 83257-008 by Biocon Biologics Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1. Structural formula of insulin aspart-xjhz - image 01

Figure 1. Structural formula of insulin aspart-xjhz - image 01

Figure 2. Serial mean serum glucose collected up to 6 hours following a single 0.15 units/kg pre-meal dose of insulin aspart (solid curve) or regular human insulin (hatched curve) injected immediately before a meal in 22 patients with type 1 diabetes - image 02

Figure 2. Serial mean serum glucose collected up to 6 hours following a single 0.15 units/kg pre-meal dose of insulin aspart (solid curve) or regular human insulin (hatched curve) injected immediately before a meal in 22 patients with type 1 diabetes - image 02

Figure 4 - image 03

Figure 4 - image 03

Instructions for Use Prefilled Pen - image 04

Instructions for Use Prefilled Pen - image 04

Not available.*

Image-5 Instructions for Use Vial - image 05

Image-5 Instructions for Use Vial - image 05

Image-6: Instructions for Use Dose Vial - image 06

Image-6: Instructions for Use Dose Vial - image 06

Image-7: Instructions for Use Vial Figures A and B - image 07

Image-7: Instructions for Use Vial Figures A and B - image 07

Image-8: Instructions for Use Vial Figure C - image 08

Image-8: Instructions for Use Vial Figure C - image 08

Image-9:Instructions for Use Vial Figure D - image 09

Image-9:Instructions for Use Vial Figure D - image 09

image-10:Instructions for Use Vial Figure E - image 10

image-10:Instructions for Use Vial Figure E - image 10

Image-11:Instructions for Use Vial Figures F and G - image 11

Image-11:Instructions for Use Vial Figures F and G - image 11

Image-12:Instructions for Use Vial Figure H - image 12

Image-12:Instructions for Use Vial Figure H - image 12

Image-13:Instructions for Use Vial Figure I - image 13

Image-13:Instructions for Use Vial Figure I - image 13

Image-14:Instructions for Use Vial Figure J - image 14

Image-14:Instructions for Use Vial Figure J - image 14

image-15:Instructions for Use Vial Figure K - image 15

image-15:Instructions for Use Vial Figure K - image 15

Image-16:Instructions for Use Vial Figure L - image 16

Image-16:Instructions for Use Vial Figure L - image 16

Figure 3. Mean blood glucose profiles following intravenous infusion of insulin aspart (hatched curve) and regular human insulin (solid curve) in 16 patients with type 1 diabetes. R represents the time of autonomic reaction. - image 17

Figure 3. Mean blood glucose profiles following intravenous infusion of insulin aspart (hatched curve) and regular human insulin (solid curve) in 16 patients with type 1 diabetes. R represents the time of autonomic reaction. - image 17

This is a set of mean blood glucose levels measured at different time points. The blood glucose levels are shown in milligrams per deciliter (mg/dL) and decrease from 180 to 54. The time axis indicates intervals of 10 minutes. Slashes on the profile indicate a change or jump on the time axis.*

Instructions for Use Prefilled Pen Ultra-Fine - image 18

Instructions for Use Prefilled Pen Ultra-Fine - image 18

Instructions for Use Prefilled Pen Figure A - image 19

Instructions for Use Prefilled Pen Figure A - image 19

Instructions for Use Prefilled Pen Figure B - image 20

Instructions for Use Prefilled Pen Figure B - image 20

Instructions for Use Prefilled Pen Figure C - image 21

Instructions for Use Prefilled Pen Figure C - image 21

Instructions for Use Prefilled Pen Figure D - image 22

Instructions for Use Prefilled Pen Figure D - image 22

Instructions for Use Prefilled Pen Figure E - image 23

Instructions for Use Prefilled Pen Figure E - image 23

Instructions for Use Prefilled Pen Figure F - image 24

Instructions for Use Prefilled Pen Figure F - image 24

Instructions for Use Prefilled Pen Figure G - image 25

Instructions for Use Prefilled Pen Figure G - image 25

Instructions for Use Prefilled Pen Figure H - image 26

Instructions for Use Prefilled Pen Figure H - image 26

Instructions for Use Prefilled Pen Figure I - image 27

Instructions for Use Prefilled Pen Figure I - image 27

Instructions for Use Prefilled Pen Figure J - image 28

Instructions for Use Prefilled Pen Figure J - image 28

Instructions for Use Prefilled Pen Figure K - image 29

Instructions for Use Prefilled Pen Figure K - image 29

image-33 - image 33

image-33 - image 33

image-34 - image 34

image-34 - image 34

image-35 - image 35

image-35 - image 35

This text appears to be a medical description of a medication called "Kirsty- (insulin aspart-xjhz) injection" with a concentration of 100 units/mL (U-100). The medication is intended for subcutaneous use and is for single-patient use only. The packaging includes five prefilled pens. The text also mentions instructions for dispensing from a sealed carton. The medication is manufactured by Biocon Biologics. Additional details regarding lot number, expiration date, and serialization are provided on the packaging.*

image-36 - image 36

image-36 - image 36

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.